Small- and medium-sized firms advised to develop their own R&D strategies

Published: 2003-11-11 06:58:00

Updated: 2003-11-11 06:58:00

Business sources say that except for a small number of large pharmaceutical firms, about 400 small- and medium-sized firms in Korea are facing fierce competition among makers with excessive number of me-too products but without profit-making ones, and this has resulted in slashing their operating...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK